An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...
FILE - The anti-viral drug Paxlovid is displayed in New York, Aug. 1, 2022. For some people with COVID-19, antiviral pills that can be taken at home can lessen the chances of winding up in the ...
But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long acknowledged and worked to rectify: For many, getting access to the ...
Hosted on MSN
J&J's experimental antiviral drug shows promise against COVID-19 and emerging coronaviruses
Johnson & Johnson’s pharmaceutical arm, Janssen, has shared early preclinical findings on its new antiviral drug, JNJ-9676, which shows promise in combating COVID-19 and other serious coronaviruses.
In patients with AF and COVID-19 who receive DOAC, 30-day mortality risk is similar for nirmatrelvir/ritonavir and RdRp inhibitors.
BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a ...
It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...
Q. I’m immunocompromised and take medication for high blood pressure, irregular heartbeat and cholesterol. I tested positive for COVID-19 and the flu while traveling to California. Probably the plane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results